861
Participants
Start Date
November 2, 2021
Primary Completion Date
June 17, 2022
Study Completion Date
November 15, 2022
Ad26.COV2.S
Ad26.COV2.S will be administered as an IM injection.
Placebo
Placebo will be administered as an IM injection.
Influenza Vaccine
Influenza vaccine high and standard dose will be administered as IM injection.
Institute of Tropical Medicine Antwerp, Antwerp
Clinical Pharmacology Unit, Merksem
Anima, Alken
Private Practice RESPISOM Namur, Namur
Rochester Clinical Research, Inc, Rochester
Clinical Research Partners, LLC, Richmond
Carolina Institute for Clinical Research, Fayetteville
Coastal Carolina Research Center, North Charleston
Clinical Research of South Florida, an AMR Company, Coral Gables
Office of Emilio Mantero-Atienza, MD, Miami
University of Miami Health System, Miami
Premier Research Associate, Inc, Miami
AMR Fort Myers Clinical Physiology Associates, an AMR company, Fort Myers
Medisphere Medical Research Center, Llc, Evansville
Meridian Clinical Research, LLC, Norfolk
Research Your Health, Plano
Ventavia Research Group, LLC, Keller
Fiel Family and Sports Medicine Clinical Research Advantage, Tempe
Clinical Research Consortium, an AMR company, Las Vegas
Wr McCr Llc, San Diego
I.D. Care, Inc., Hillsborough
Synexus Polska Sp. z o.o. Oddzial w Czestochowie, Częstochowa
Synexus Polska Sp. z o.o. Oddzial w Gdansku, Gdansk
Gdanskie Centrum Zdrowia, Gdansk
Synexus Polska Sp. z o.o. Oddzial w Gdynia, Gdynia
Synexus Polska Sp z o o Oddzial w Katowicach, Katowice
Synexus Polska Sp Z O O Oddzial W Lodzi, Lodz
Synexus Polska Sp. z.o.o. Oddzial w Poznaniu, Poznan
Centrum Medyczne Pratia Poznan, Skorzewo
Synexus Polska Sp z o o Oddzial w Warszawie, Warsaw
Synexus Polska Sp z o o Oddzial we Wroclawiu, Wroclaw
Janssen Vaccines & Prevention B.V.
INDUSTRY